Siemens Healthineers  

Tarrytown,  NY 
United States
http://usa.siemens.com/Healthineers
  • 1039

Booth Profile

At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, and improving patient experience, all enabled by digitalizing healthcare. An estimated 5 million patients globally every day benefit from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With more than 48,000 dedicated colleagues in 75 countries, we will continue to innovate and shape the future of healthcare.


 Products

  • Atellica® Diagnostics IT
    Atellica® Diagnostics IT simplifies operations in the lab. Our innovative, next-generation portfolio leverages 20 years of IT and automation leadership to optimize laboratory workflow with open, scalable solutions, advanced analytics, and business intelligence....

  • Atellica® Diagnostics IT is helping labs manage increasing workloads, staffing challenges, and decreasing budgets with innovative data-driven solutions. See how we’ve applied knowledge gained from 20 years of IT and automation leadership to bring simplicity to your day-to-day operations. 

    • Minimize operator intervention by streamlining workflows with our powerful, open and scalable solution

    • Transform your laboratory with immediate oversight and control through advanced analytics and business intelligence

    • Reduce costs and save time with the automated, real-time control of consumables across multiple locations

      Visit us at booth # 1039 and see how Atellica Diagnostics IT can take the work out of your workflow.

    Product availability may vary by country and is subject to varying regulatory requirements.

  • Atellica® Process Manager
    Atellica® Process Manager provides data-driven insight to help labs control and optimize workflow. With over 10 standard reports available right out of the box—including TAT, reagent efficiency, and automation utilization—labs can better balance system workloads and track real-time KPIs to determine and correct errors that cost time and money....

  • Atellica® Process Manager helps you do more than control workflow and processes, it enables you to uncover inefficiencies and optimize clinical operations to save time and money.

    • Standardize and optimize clinical operations across your laboratory through built-in analytics and business intelligence capabilities.
    • Determine and correct errors that occur in the preanalytic, analytic, and post-analytic stages with advanced performance metrics.
    • Increase staff productivity with centralized oversight, including the ability to control all systems, view reagent levels and testing exceptions from one screen.
    • Deliver transparent and predictable turnaround times through rules and at-risk sample alerts.

    Product availability may vary by country and is subject to varying regulatory requirements.

  • Atellica® Data Manager
    Atellica® Data Manager helps standardize testing, enhance quality control, and streamline result management across diagnostics networks. A culmination of 20 years’ experience in data management, the powerful features and easy navigation of our newest open, scalable, next-generation middleware deliver even greater simplicity and innovation....

  • Atellica® Data Manager helps standardize testing, enhance quality control, and streamline result management. See how the powerful features and easy navigation of our open, scalable next-generation software builds on our 20 years of experience in data mangement  to:

    • Increase workforce productivity and staff utilization by enhancing visibility, automating processes, automatically verifying results, and centralizing management across instruments, automation, sites, and networks

    • Optimize clinical operations by reducing costs, improving efficiency and predictability, and sharpening clinical focus on exceptions

    • Reduce errors by standardizing testing protocols, enabling consistent review and reporting of results, and proactively managing QC

    Product availability may vary by country and is subject to varying regulatory requirements.

  • epoc® Blood Analysis System
    Improve outcomes and workflow while transforming care delivery across clinical pathways. The handheld epoc® Blood Analysis System gives you lab-quality results here and now. The epoc system helps to improve the patient experience and clinical outcomes by providing the right test in the right place at the right time. ...

  • Streamline the patient testing process and aid clinicians in making faster decisions with the handheld epoc® Blood Analysis System, offering real-time, lab quality results at the patient’s side. Simplify inventory management of reagents and maximize efficiencies with the epoc system’s room-temperature stable single use test cards, and provide results for a full panel of tests in less than 1 minute. By moving testing to the patient’s side, caregivers, patients, and hospital administration all benefit from a less complex testing process.

  • ARK Fentanyl assay on the Atellica® CH Analyzer
    The ARK Fentanyal assay is in development as an Alliance Application on Siemens Healthineers chemistry systems including the Atellica® CH Analyzer. The assay measures fentanyl in human urine. Fentanyl is a synthetic opioid similar to morphine, prescribed for patients with chronic pain, post-operative pain, or breakthrough pain in cancer patients....

  • The ARK Fentanyl assay is in development as an Alliance Application on Siemens Healthineers chemistry systems including the Atellica® CH Analyzer. It measures fentanyl in human urine. Fentanyl is a synthetic opioid similar to morphine, prescribed for patients with chronic pain, post-operative pain, or  treat breakthrough pain in cancer patients. The ARK Fentanyl assay demonstrates cross-reactivity with norfentanyl. Detecting norfentanyl is clinically important due to the quick metabolization of fentanyl into norfentanyl, its major metabolilte. The potency of fentanyl and the alarming increase of misuse and abuse poses an overdose danger, often unintentional.

    Under development. The performance characteristics of this device have not been established. Not available for sale. Product availability may vary by country and is subject to varying regulatory requirements.

  • Atellica Asa™ Application†
    Siemens Healthineers continues to invest in innovations for the Atellica® Solution.* The design goal of Atellica Asa™ Application† is to be a virtual assistant for your lab to help to improve workflow by simplifying and organizing operator interactions in an easy-to-navigate, tile-based application....

  • Siemens Healthineers continues to invest in innovations for the Atellica® Solution.* The design goal of Atellica Asa™ Application is to be a virtual assistant for your lab that will help to improve workflow by simplifying and organizing operator interactions in an easy-to-navigate, tile-based application.

    Its design goal is to draw attention to only the most common but critical procedures needed for daily operation of the Atellica® Solution,* minimizing the need to access multiple screens to complete a single task.

    *Product availability varies by country.

    †Under development. Features listed are development design goals. Future availability cannot be guaranteed.

  • Atellica® CH Enzymatic Hemoglobin A1c Assay
    The Enzymatic Hemoglobin A1c assay for the Atellica CH Analyzer is now available to meet the growing demand for HbA1c testing. It aids in the diagnosis and monitoring of long-term blood glucose control in patients with diabetes mellitus. It’s an easy-to-implement chemistry test, offering precise and accurate results for diabetic patient management....

  • The Enzymatic Hemoglobin A1c assay for the Atellica CH Analyzer is now available to meet the increasing demand for HbA1c testing. It aids in the diagnosis and monitoring of long-term blood glucose control in patients with diabetes mellitus and identification of those at risk for developing diabetes mellitus.

    Diabetes is a growing global problem and the increased demand for diabetes testing is a challenge for clinical laboratories. The new Siemens Healthineers Atellica CH Enzymatic Hemoglobin A1c Assay is a NGSP certified assay and traceable to the IFCC reference calibrators. It provides precision and accuracy needed to meet new industry standards, and the automation to improve throughput compared to traditional HPLC assays.

  • Atellica® Decapper*
    Sieme Healthineers continues to invest in workflow innovations for the Atellica® Solution.† An integrated suite of sample-management possibilities,* including the Atellica® Decapper,* is under development, with the goal of bringing more control and simplicity to the lab through customized solutions for Atellica Solution stand-alone configurations.*...

  • Siemens Healthineers continues to invest in workflow innovations for the Atellica® Solution—flexible, scalable chemistry and immunoassay analyzers engineered to bring control and simplicity to the lab, so you can focus on driving better outcomes.

    An integrated suite of sample-management possibilities,* including the Atellica® Decapper,* is under development, with the goal of bringing more control and simplicity to the lab. The Atellica Decapper* is being designed with the goal of integrating decapping into the analytical workflow of Atellica Solution stand-alone configurations with little to no additional footprint to accommodate workflow and space requirements.

    *Under development. Not available for sale. Features listed are development design goals. Future availability cannot be guaranteed.

    †Product availability varies by country.

  • The Enhanced Liver Fibrosis (ELF™) Test*
    Non-alcoholic fatty liver disease (NAFLD) is projected to become the leading cause of liver-related mortality within 20 years. The Siemens Healthineers Enhanced Liver Fibrosis (ELF™) Test* on the Atellica® IM Analyzer and ADVIA Centaur® System is a prognostic marker designed to assess the risk of disease progression and clinical events....

  • Non-alcoholic fatty liver disease (NAFLD) impacts over 1 billion globally and is projected to become the leading cause of liver-related mortality within 20 years. Because of the increasing global burden, the lack of appropriate non-invasive testing options is a major concern.

    The Siemens Healthineers Enhanced Liver Fibrosis (ELF™) Test* on the Atellica® IM Analyzer and ADVIA Centaur® Immunoassay System combines three biomarkers in a proprietary algorithm, is a prognostic marker in patients with chronic liver disease, and is designed to assess the risk of disease progression and liver-related clinical events. Multiple publications have shown the ELF test is a valuable non-invasive test in multiple areas of NAFLD and NASH patient management.

    *Not available for sale in the U.S. Future availability cannot be guaranteed. Product availability may vary by country.

  • LifeNet
    LifeNet is your faster connection to insights in digitalizing healthcare. LifeNet is your online portal to manage the performance and maintenance of your Siemens Healthineers equipment, 24/7, from any device....

  • LifeNet is an online portal that allows you to manage the performance and maintenance of your Siemens Healthineers equipment, 24/7, from any device. An array of features provides extensive transparency and efficient workflows, enabling you to maintain visibilty and control at all times. If you are planning mainenance activities, would like to monitor the staus of  your equipment and service requests, or document service history: LifeNet is your answer.

          Plan ahead: Maximize your equipment's productivity

          Monitor effieciently: View your equipment status and maintain control

          Manage effectively: Access data on demand to meet your needs

  • RAPIDPoint® 500e Blood Gas System
    The RAPIDPoint 500e Blood Gas System has been designed to be the next generation of innovation from Siemens Healthineers, elevating your blood gas solution to a new level and allowing you to spend more time focused on patient care. Our goal is to elevate your blood gas solution, enabling you to deliver high-value care....

  • The RAPIDPoint 500e Blood Gas System has been designed to be the next generation of innovation from Siemens Healthineers, elevating your blood gas solution to a new level and allowing you to spend more time focused on patient care. With its redesigned user interface and upgraded hardware and software, the RAPIDPoint 500e system has been designed to deliver an intuitive, heightened user experience. RAPIDPoint systems incorporate our proprietary Integri-sense™ Technology, intended to deliver confidence with every result. Our goal is to elevate your blood gas solution with the RAPIDPoint 500e Blood Gas System, enabling you to deliver high-value care.

    *Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability. Under development. Not available for sale in the U.S. 


 Additional Info

Included in the Export Interest Directory?
No
Countries of Interest:
1. All Countries listed below